Order Article Reprints

Abdel-Mohsen HT, Abdullaziz MA, El Kerdawy AM, Ragab FAF, Flanagan KJ, Mahmoud AEE, Ali MM, El Diwani HI, Senge MO. Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles. Molecules. 2020; 25(4):770. https://doi.org/10.3390/molecules25040770

Abdel-Mohsen, Heba T., Mona A. Abdullaziz, Ahmed M. El Kerdawy, Fatma A. F. Ragab, Keith J. Flanagan, Abeer E. E. Mahmoud, Mamdouh M. Ali, Hoda I. El Diwani, and Mathias O. Senge. 2020. "Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles" Molecules 25, no. 4: 770. https://doi.org/10.3390/molecules25040770

Abdel-Mohsen, H. T., Abdullaziz, M. A., El Kerdawy, A. M., Ragab, F. A. F., Flanagan, K. J., Mahmoud, A. E. E., Ali, M. M., El Diwani, H. I., & Senge, M. O. (2020). Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles. Molecules, 25(4), 770. https://doi.org/10.3390/molecules25040770